Ccr2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
CCR2 (C-C Motif Chemokine Receptor 2) is a G protein-coupled receptor that binds multiple CC chemokines including CCL2 (MCP-1), CCL7, CCL8, and CCL13. It is primarily expressed on monocytes, macrophages, and microglia, and plays a critical role in immune cell trafficking and neuroinflammation.
The CCR2-CCL2 axis is a major signaling pathway governing monocyte recruitment to the central nervous system. In neurodegenerative diseases, this pathway contributes to both the protective clearance of pathological aggregates and the harmful amplification of neuroinflammation. Genetic variants in CCR2 have been studied for their association with Alzheimer's Disease and multiple sclerosis susceptibility.
CCR2 is a G protein-coupled receptor that binds multiple CC chemokines including CCL2 (MCP-1), CCL7, CCL8, and CCL13. It is primarily expressed on monocytes, macrophages, and microglia, and plays a critical role in immune cell trafficking and neuroinflammation.
CCR2 is expressed on:
The study of Ccr2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010;140(6):918-934. DOI:10.1016/j.cell.2010.02.016
Heneka MT, Carson MJ, El Khoury J, et al. Neuroinflammation in Alzheimer's disease. Lancet Neurol. 2015;14(4):388-405. DOI:10.1016/S1474-4422(1570016-5
Ransohoff RM. How neuroinflammation contributes to neurodegeneration. Science. 2016;353(6301):777-783. DOI:10.1126/science.aag2590
Song WM, Colonna M. The identity and function of microglia in neurodegeneration. Nat Immunol. 2018;19(10):1048-1058. DOI:10.1038/s41590-018-0212-1
Wolf Y, Yona S, Kim KW, Jung S. Microglia, seen from the TNF side. Nat Rev Immunol. 2017;17(1):49. DOI:10.1038/nri.2016.144
Prinz M, Priller J. The role of peripheral immune cells in the CNS in steady state and disease. Nat Neurosci. 2017;20(2):136-144. DOI:10.1038/nn.4475
Deczkowska A, Amit I, Schwartz M. Microglial immune checkpoint mechanisms. Nat Neurosci. 2018;21(6):779-781. DOI:10.1038/s41593-018-0144-y
Keren-Shaul H, Spinrad A, Weiner A, et al. A unique microglia type associated with restricting development of Alzheimer's disease. Cell. 2017;169(7):1276-1290.e17. DOI:10.1016/j.cell.2017.05.018